BlackRock’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,538,770
Closed -$259M 5457
2023
Q2
$259M Buy
2,538,770
+329,021
+15% +$33.5M 0.01% 1393
2023
Q1
$201M Sell
2,209,749
-292,209
-12% -$26.6M 0.01% 1519
2022
Q4
$95M Buy
2,501,958
+6,587
+0.3% +$250K ﹤0.01% 2019
2022
Q3
$62.7M Buy
2,495,371
+335,724
+16% +$8.44M ﹤0.01% 2259
2022
Q2
$65.6M Buy
2,159,647
+83,887
+4% +$2.55M ﹤0.01% 2280
2022
Q1
$68M Sell
2,075,760
-38,290
-2% -$1.25M ﹤0.01% 2356
2021
Q4
$55.7M Sell
2,114,050
-6,672
-0.3% -$176K ﹤0.01% 2558
2021
Q3
$213M Sell
2,120,722
-15,049
-0.7% -$1.51M 0.01% 1654
2021
Q2
$302M Buy
2,135,771
+651,773
+44% +$92.2M 0.01% 1459
2021
Q1
$148M Buy
1,483,998
+68,485
+5% +$6.83M ﹤0.01% 1926
2020
Q4
$175M Buy
1,415,513
+39,429
+3% +$4.87M 0.01% 1704
2020
Q3
$134M Sell
1,376,084
-230,646
-14% -$22.5M ﹤0.01% 1680
2020
Q2
$251M Sell
1,606,730
-516,649
-24% -$80.6M 0.01% 1191
2020
Q1
$306M Sell
2,123,379
-120,492
-5% -$17.4M 0.02% 874
2019
Q4
$459M Buy
2,243,871
+288,641
+15% +$59M 0.02% 850
2019
Q3
$157M Buy
1,955,230
+39,523
+2% +$3.17M 0.01% 1584
2019
Q2
$181M Buy
1,915,707
+58,853
+3% +$5.55M 0.01% 1504
2019
Q1
$159M Sell
1,856,854
-101,310
-5% -$8.66M 0.01% 1568
2018
Q4
$110M Buy
1,958,164
+29,802
+2% +$1.67M 0.01% 1718
2018
Q3
$158M Buy
1,928,362
+424,582
+28% +$34.7M 0.01% 1644
2018
Q2
$52.6M Buy
1,503,780
+311,924
+26% +$10.9M ﹤0.01% 2320
2018
Q1
$24.4M Sell
1,191,856
-12,137
-1% -$249K ﹤0.01% 2643
2017
Q4
$34.1M Buy
1,203,993
+307,636
+34% +$8.71M ﹤0.01% 2477
2017
Q3
$27.9M Buy
896,357
+437,874
+96% +$13.6M ﹤0.01% 2591
2017
Q2
$14.5M Buy
458,483
+105,466
+30% +$3.34M ﹤0.01% 2938
2017
Q1
$8M Buy
353,017
+352,799
+161,834% +$7.99M ﹤0.01% 3183
2016
Q4
$5K Hold
218
﹤0.01% 3470
2016
Q3
$6K Sell
218
-3,659
-94% -$101K ﹤0.01% 3429
2016
Q2
$77K Buy
+3,877
New +$77K ﹤0.01% 2661